- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT03405181
Effects of the Additional Weight on the Reaching Behavior of Pre Term Infants With Low Birth Weight
21 de fevereiro de 2019 atualizado por: Prof. Rodrigo Luiz Carregaro, University of Brasilia
Effects of the Additional Weight on the Reaching Behavior of Preterm Infants With Low Birth Weight: Randomized Controlled Trial
The effects of additional weight on early motor skills of infants have been increasingly studied.
During the reaching behavior, the additional weight has been shown benefits in certain kinematic variables in full term and preterm infants.
There is a growing interest in the study of populations at risk for motor development, especially considering interventions based on functional activities with the purpose of improving the neuromotor control, functional capacity and muscle strength.
The aim of the present study is to investigate the effect of a functional training with additional weight in the reaching behavior of preterm infants with low birth weight and to compare the effects with a full term population.
A controlled and randomized trial will be carried out with full term infants of adequate birth weight and preterm infants with low birth weight at 6 months of chronological or corrected age.
The participants will be recruited by convenience from the charts of a Public Hospital.
Participants will be randomly allocated into four groups: 1) adequate weight placebo group (AWPG); 2) adequate weight intervention group (AWIG); 2) low weight placebo group (LWPG) and 4) low weight intervention group (LWIG). .
The assessor will be blinded (no knowledge of groups allocation).
All infants will undergo a training program of eight sessions (2x/week; 4 weeks).
The AWIG and LWIG will receive the training with an additional weight (characterized by a bracelet with a weight of 20% of the mass of the upper limbs)and the AWPG and LWPG will receive the same training, however, without the additional weight (only the bracelets)..
All infants will be assessed in three different moments: 1) Pre-intervention: baseline, before the start of the intervention program; 2) Post-intervention: evaluation performed after the end of the program; and 3) Follow-up: evaluation performed seven days after the post-intervention assessment.
The following kinematic dependent variables will be calculated: straightness index, mean velocity and motion units and electromyographic variables: pattern of activation and recruitment of muscle fibers - Biceps brachialis, Triceps brachialis, Deltoid and Pectoralis Major muscles; co-activation between biceps and triceps.
The Qualisys Track Manager (QTM) and a wireless surface electromyography with 8-channels will be used.
If normality assumptions are met, a mixed 2X2 ANOVA with repeated measures will be applied, in order to verify differences between the intervention programs, considering the dependent variables.
Otherwise, non-parametric procedures of the same nature will be adopted.
The significance will be set at 5% (P<0.05).
Visão geral do estudo
Status
Concluído
Intervenção / Tratamento
Tipo de estudo
Intervencional
Inscrição (Real)
66
Estágio
- Não aplicável
Contactos e Locais
Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.
Locais de estudo
-
-
DF
-
Brasília, DF, Brasil, 72220-275
- Campus UnB Ceilandia
-
-
Critérios de participação
Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.
Critérios de elegibilidade
Idades elegíveis para estudo
6 meses a 7 meses (Filho)
Aceita Voluntários Saudáveis
Sim
Gêneros Elegíveis para o Estudo
Tudo
Descrição
Inclusion Criteria:
- Adequate weight infants: healthy infants born with gestational age between 38-42 weeks and adequate birth weight (> 2500 grams);
- Low weight infants: healthy infants born with gestational age between 32-36 weeks and 6 days and with low birth weight (between 1500 and 2500 grams).
Exclusion Criteria:
- Anoxiated infants;
- Signs of neurological impairment (eg, hypoxic-ischemic encephalopathies grade I, II and III, intracranial hemorrhage and neonatal seizures);
- Congenital malformations (eg myelomeningocele and achondroplasias);
- Syndromes (e.g Down Syndrome);
- Sensorial alterations (visual and auditory);
- Cardiorespiratory difficulties;
- Orthopedic impairments (e.g, congenital clubfoot);
- Apgar below 8 and 10 in the first and fifth minutes, respectively.
- Infants who do not attend any of the evaluations, who do not complete at least 80% of the training or who cry uncontrollably, not allowing at least 10 reachings in the evaluations and training. Those that present intercurrences that may compromise normal neurosensorimotor development (for example, recurrent pneumonia, kidney and intestinal infection).
Plano de estudo
Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Solteiro
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Training with additional weight
The infants will be submitted to a reaching behavior training program of 4 weeks, two times per week (totaling 8 sessions).
During this training program, infants will use a bracelet with an additional weight characterized by 20% of the total mass of the upper limb placed on both wrists.
This training will be adopted for the adequate weight intervention group and low weight intervention group.
|
The infants will be positioned in a reclined position.
A bracelet with an additional weight (20% of the total mass of the upper limb) will be placed on both wrists.
The training will happen 2x/week, during 4 weeks (8 sessions).
An object will be used to stimulate the reaching behavior, which will be displayed by the examiner (positioned in front of the infant), and presented in the midline at shoulder height, considering the distance from the arm's length of the infant to the height of the wrist.
The physiotherapist will draw the attention of the infant to the object, moving it momentarily so that the infant perceives it and reaches it.
After reaching, the object will be carefully removed and resubmitted in order to elicit a new movement.
The interval between each presentation will be of approximately 5 seconds.
At least 10 movements will be stimulated.
If the infant does not achieve the 10 reaches within the maximum interval of 15 minutes, the session will be terminated.
|
|
Comparador de Placebo: Training without additional weight
The infants will be submitted to a reaching behavior training program of 4 weeks, two times per week (totaling 8 sessions).
During this training program, infants will use a bracelet without additional weight, placed on both wrists.
This training will be adopted for the adequate weight placebo group and low weight placebo group.
|
The infants will be positioned in a reclined position.
A bracelet without the additional weight will be placed on both wrists.
The training will happen 2x/week, during 4 weeks (8 sessions).
An object will be used to stimulate the reaching behavior, which will be displayed by the examiner (positioned in front of the infant), and presented in the midline at shoulder height, considering the distance from the arm's length of the infant to the height of the wrist.
The physiotherapist will draw the attention of the infant to the object, moving it momentarily so that the infant perceives it and reaches the object.
After reaching, the object will be carefully removed (or picked up) and resubmitted in order to elicit a new movement.
The interval between each presentation of the object will be of approximately 5 seconds.
At least 10 movements will be stimulated.
If the infant does not achieve the 10 reaches within the maximum interval of 15 minutes, the session will be terminated.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Movement unit
Prazo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
the number of maximum velocities between two minimum velocities, for which the difference was greater than 1 cm/s
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Electromyographic activity
Prazo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
Magnitude of the muscle recruitment during the reaching behavior, measured in microvolts (root mean square - RMS)
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Mean Velocity
Prazo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
the ratio between the distance traveled during the reaching behavior and the duration of the movement
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Straightness Index
Prazo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
ratio between the minimal distance that could have been traveled in this trajectory (distance between the initial position of the hand and the object) and the distance traveled by the hand (total trajectory).
The closer is this index to 1, the straighter is the trajectory.
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Grasping
Prazo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
categorical variable classified into (a) successful: when the infant was able to grasp the object with one or both hands; and (b) unsuccessful: when the infant touched the object, but did not grasp it
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Muscle coactivation
Prazo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
Coactivation between the biceps and triceps muscle during the reaching behavior, measured in percentage (activation of the biceps/activation of the triceps)
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Transport Unit
Prazo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
The relative duration of the first movement unit in relation to total duration of reaching
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
|
Deceleration time
Prazo: Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
The time necessary for the infant to decelerate the arm movement so that the hand touches an object.
This period of the duration is measured from the time of appearance of the peak of velocity to the end of the reach.
|
Change from Pre-Intervention (baseline) compared to Post-Intervention (4 weeks) and Follow-up (7 days)
|
Colaboradores e Investigadores
É aqui que você encontrará pessoas e organizações envolvidas com este estudo.
Patrocinador
Investigadores
- Diretor de estudo: Rodrigo Carregaro, PhD, University of Brasilia
Datas de registro do estudo
Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.
Datas Principais do Estudo
Início do estudo (Real)
12 de janeiro de 2018
Conclusão Primária (Real)
15 de setembro de 2018
Conclusão do estudo (Real)
15 de setembro de 2018
Datas de inscrição no estudo
Enviado pela primeira vez
12 de janeiro de 2018
Enviado pela primeira vez que atendeu aos critérios de CQ
18 de janeiro de 2018
Primeira postagem (Real)
19 de janeiro de 2018
Atualizações de registro de estudo
Última Atualização Postada (Real)
25 de fevereiro de 2019
Última atualização enviada que atendeu aos critérios de controle de qualidade
21 de fevereiro de 2019
Última verificação
1 de fevereiro de 2019
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- Additional Weight Trial
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
NÃO
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Não
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Não
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .
Ensaios clínicos em Baixo peso de nascimento
-
Cancer Institute and Hospital, Chinese Academy...RecrutamentoHER2-Low Low irressectável/metastático câncer de mama complicado com crise visceralChina
-
National Taiwan University HospitalBuddhist Tzu Chi General Hospital; Taipei Medical University Hospital; E-DA Hospital e outros colaboradoresDesconhecidoColonoscopia | Limpeza do cólon | Dieta Low-ResideTaiwan
-
Shanghai Henlius BiotechRecrutamentoHER2-Low Hormon Receptor positivo Câncer de mamaChina
-
Aminex Therapeutics, Inc.RecrutamentoMelanoma (câncer de pele) | HER2-Low Hormon Receptor positivo Câncer de mamaEstados Unidos
-
Yeon Hee ParkHelsinn Healthcare SAInscrevendo-se por convitePacientes com câncer de mama avançado positivo para HER2 tratado com T-DXD | Pacientes com câncer de mama Avançado com HER2-Low tratado com T-DXDCoréia do Sul
-
National Cancer Institute (NCI)RecrutamentoCâncer de Mama Anatômico Estágio III AJCC v8 | Câncer de Mama Anatômico Estágio IV AJCC v8 | Neoplasia sólida maligna irressecável | Neoplasia Sólida Maligna Metastática | Carcinoma de Mama Invasivo | Carcinoma de mama irressecável | Carcinoma de Mama Triplo Negativo Metastático | Carcinoma de Mama... e outras condiçõesEstados Unidos
-
BicycleTx LimitedAtivo, não recrutandoNeoplasias da Mama | Neoplasias da Mama Triplo Negativas | Tumor Sólido Avançado | Neoplasia ovariana | Neoplasia da Bexiga Urinária | Neoplasias positivas para receptor hormonal e negativas para HER2 | Receptor hormonal positivo, neoplasias HER2-low | Neoplasias pulmonares de células não pequenasFrança, Estados Unidos, Espanha, Reino Unido, Itália, Canadá
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...Fondazione Policlinico Universitario Agostino Gemelli IRCCS; Fondazione IRCCS... e outros colaboradoresRecrutamentoCâncer de mama | Neoplasias da Mama | Doenças da mama | Neoplasia de Mama | Tumores de mama | Carcinoma de mama | Neoplasias da Mama, Masculino | Câncer de Mama Estágio IV | Neoplasia Maligna da Mama Receptor Hormonal Positivo | Câncer de Mama RH positivo | Carcinoma de Mama Receptor Hormonal Positivo | Câncer... e outras condiçõesItália